Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug market
Pharma
Radicava stalls in EU as skeptical regulators demand new ALS trial
Mitsubishi Tanabe’s Radicava touted its FDA approval as a win for ALS patients. But on the clinical data that backed it, the EU wants to see more.
Kyle Blankenship
May 31, 2019 12:19pm
New launches Rexulti, Trintellix steer Lundbeck to best H1 ever
Aug 10, 2017 12:02pm
Roche's Perjeta chalks up needed win in combo trial
Mar 2, 2017 11:27am
Cancer vax market said to triple to $7.5B by 2022
Nov 21, 2016 8:19am
FDA device rebuff thwarts Abilify's adherence boost
Apr 28, 2016 11:44am